Research

Researchers Develop Marburg Virus Treatment Effective Five Days After Infection

Virus causes hemorrhagic fever often leading to death


By Donna Ramirez | April 07, 2017

An antibody treatment successfully protected nonhuman primates against the deadly Marburg and Ravn viruses even when given five days after becoming infected, according to the latest findings of a collaborative team from The University of Texas Medical Branch at Galveston, Mapp Biopharmaceutical Inc., and Vanderbilt University. The findings are now available in Science Translational Medicine.

There are currently no vaccines or drugs approved for human use to protect against the Marburg and Ravn viruses. These two filoviruses, which are in the same virus family as Ebola, cause severe and often lethal disease in people. The average case fatality rate of Marburg virus disease since the first recognized outbreak in 1967 is 80 percent.

Monoclonal antibodies are a technology that is currently in wide use for treating autoimmune diseases and cancers. There are more than 45 monoclonal antibodies approved by the U.S. Food and Drug Administration and European Medicines Agency.

“In this paper, we demonstrated that one monoclonal antibody is able to protect up to 100 percent of Marburg or Ravn virus-infected non-human primates when the antibody treatment is given up to five days following exposure to a lethal amount of the virus,” said UTMB’s Thomas Geisbert, professor in the department of microbiology and immunology. “These findings extend the growing body of evidence that monoclonal antibodies can provide protection during advanced stages of disease with highly dangerous viruses and could be useful during an epidemic.”

The study was conducted in Biosafety Level (BSL)-4 at UTMB’s Galveston National Laboratory. BSL-4 is a highly-restricted area where scientists wear positive pressure protective suits and study pathogens that cause severe and often fatal diseases. UTMB has the only functioning BSL-4 laboratory located on an American university campus.

The 2013 to 2016 Ebola virus epidemic highlighted the troubling lack of preventive or treatment options for filoviruses. Some of the therapeutics used to treat those infected with Ebola were developed and tested in the GNL.

“The level of protection observed by Dr. Geisbert’s team with this antibody is very impressive. We plan to advance this product towards human safety testing as quickly as possible,” said Larry Zeitlin, president of Mapp Biopharmaceutical Inc.

Other authors of this paper include UTMB’s Chad Mire, Joan Geisbert, Viktoriya Borisevich, Karla Fenton, Krystle Agans and Daniel Deer; Andrew Flyak and James Crowe, Jr. from Vanderbilt University Medical Center; Herta Steinkellner from the University of Natural Resources and Life Sciences in Vienna and Ognian Bohorov, Natasha Bohorova, Charles Goodman, Andrew Hiatt, Do Kim, Michael Pauly, Jesus Velasco and Kevin Whaley.

This study was supported by the Department of Health and Human Services, National Institutes of Health and BSL-4 operations support of the Galveston National Laboratory.

Tags | Research



Social Posts

profile_image

Houston Methodist

@MethodistHosp

@PacBio Thanks for sharing ^SF

40 mins ago
profile_image

BCMHouston

@bcmhouston

RT @BCMHouston_News: .@bcmhouston @BCMEmergencyMed research finds high rates of duplicate emergency visits for uninsured patients. https://?

44 mins ago
profile_image

Houston Methodist

@MethodistHosp

@DreamFighter22 Thanks for letting us know. We'll pass this along. ^SF

1 hour ago
profile_image

Rice University

@RiceUniversity

Outstenting: National Institutes of Health backs students? design. https://t.co/VaN4HXES9W https://t.co/UAtGaVbTzl

1 hour ago
profile_image

UTHealth

@UTHealth

RT @UTexasSPH: The Student Epidemic Intelligence Society were featured in the ASPPH news for relief efforts after Hurricane Harvey. https:/?

1 hour ago
profile_image

UTHealth

@UTHealth

RT @UTHealthWIC: Quick tips for healthy eating! Consejos para alimentacin saludable! https://t.co/idZRk3sTFE

1 hour ago
profile_image

UTHealth

@UTHealth

RT @UTPhysicians: Weight and health issues left a Texas teen with a bleak outlook, until a new doctor and plan transformed her life. https:?

1 hour ago
profile_image

Rice University

@RiceUniversity

??? https://t.co/CbglhYKagk

1 hour ago
profile_image

Texas Children's

@TexasChildrens

We are at #PLAY60AtThePark with the @HoustonTexans until 7pm! Join us in helping kids across Houston get active and? https://t.co/sYsMBR44JZ

1 hour ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veterans organization urges vets to seek help if Vietnam documentary triggers difficult memories https://t.co/6vXBghpl7x via @WXXINews

1 hour ago
profile_image

BCMHouston

@bcmhouston

The Baylor College of Medicine Wellness 5K takes place on Saturday, Oct. 21. Learn more and register today. https://t.co/AHLVwRA3gV

2 hours ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Congratulations to Sarah Keyes, who received a 5-year Health Resources and Services Administration (HRSA) grant!

2 hours ago
profile_image

Texas Children's Hospital

TexasChildrensHospital

Rice University's seventh annual Hackathon’s new health care track pitted competitors against one another in a race to develop new software and hardware to solv...

2 hours ago
profile_image

Rice University

RiceUniversity

Rice University will host a memorial service for David Minter on October 9 at 3 p.m. in the Rice Chapel. A pillar of the Rice community, Minter was a former E...

2 hours ago
profile_image

MD Anderson

@MDAndersonNews

Singer doesn?t let vocal cord cancer silence him: https://t.co/qmSMgzOR73 #throatcancer #tcsm #endcancer https://t.co/s1QqWBxArh

2 hours ago